Skip to main content

Global Medication Reference Center

Global Medication Reference Center

NAPPSA Intelligence Center

Global Medication Reference Center

Quick access to official brand and generic medication labeling, regulatory status, generic-equivalence resources, and country-specific product registries for practitioners.

United States · Official labeling

DailyMed Drug Labels

Current in-use prescription and nonprescription labeling submitted to FDA, including indications, dosing, warnings, adverse reactions, interactions, pregnancy information, and product identifiers.

Open DailyMed

United States · Approval status

Drugs@FDA

Search FDA-approved human drugs by drug name, active ingredient, or application number. Includes approval history, labeling, regulatory information, and FDA reviews when available.

Open Drugs@FDA

United States · Generic equivalence

FDA Orange Book

Use for FDA therapeutic-equivalence evaluations, approved generic products, dosage forms, strengths, patents, exclusivity, and application information.

Open Orange Book

United States · Brand–generic crosswalk

RxNorm / RxNav

National Library of Medicine terminology for connecting brand names, generic ingredients, strengths, dose forms, and normalized medication concepts.

Open RxNav

Nigeria · Registered products

NAFDAC Greenbook

Nigeria’s registered product database. Search by product name, active ingredient, NAFDAC registration number, applicant, manufacturer, dosage form, route, strength, and approval status.

Open NAFDAC Greenbook

Alternatives · Clinical use

Medication Alternatives

Generic equivalents should be confirmed through regulatory equivalence sources. Therapeutic alternatives are different drugs that may serve a similar clinical purpose but require review of indication, evidence, contraindications, organ function, interactions, formulary, cost, and patient preference.

Use guideline-based alternatives

Other jurisdictions

Regional Medication Registries

For medicines used outside the jurisdictions listed here, consult the relevant national medicines regulator. Approval, labeling, availability, and brand names can differ by country.

Suggest an official registry for review

Practitioner safety notice

This center is a discovery and reference gateway, not a prescribing engine. Verify the complete current monograph, approved indication, formulation, strength, route, patient-specific factors, local registration status, and applicable treatment guidelines. Brand availability and formulation can differ by country. Do not interpret a therapeutic-class match as automatic interchangeability.